Merck & Co., Inc. (BCBA:MRK)

Argentina flag Argentina · Delayed Price · Currency is ARS
21,750
-150 (-0.68%)
At close: Aug 14, 2025, 5:00 PM BRT
-25.26%
Market Cap 273.12T
Revenue (ttm) 75.81T
Net Income (ttm) 19.55T
Shares Out n/a
EPS (ttm) 7,728.34
PE Ratio 13.97
Forward PE 9.15
Dividend 435.90 (2.00%)
Ex-Dividend Date Jun 13, 2025
Volume 4,061
Average Volume 6,802
Open 21,925
Previous Close 21,900
Day's Range 21,575 - 22,025
52-Week Range 16,950 - 31,600
Beta 0.39
RSI 57.98
Earnings Date Jul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.